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ABSTRACT 
Background:  Soft tissue lasers and certain hard tissue laser have been used in the treatment of 
oral mucosal lesions. This study was an attempt to compare soft tissue laser and hard tissue laser 
in treating oral leukoplakia. 
Aim & Objective: To compare the effectiveness of Diode Laser and Er,Cr:YSGG Laser in 
treating oral leukoplakia by assessing intraoperative pain and bleeding and postoperative pain on 
the following seven postoperative days as well as wound healing on the 7
th
, 14
th
 and 21
st
 post-
operative days. 
Methodology: The study population included five patients, above the age of 18 years, 
provisionally diagnosed and histopathologically confirmed as having oral leukoplakia. In each 
patient part of the lesion was treated with Diode laser and the rest with Er,Cr:YSGG laser. Each 
patient was assessed individually during both laser procedures for intraoperative pain and 
bleeding during procedure, for postoperative pain on the following seven post-operative days and 
for wound healing on the 7
th
, 14th and 21
st
 day after treatment. Pain was assessed using three 
different pain rating scales and wound healing using visual method. 
Results: Using Diode laser caused minimal to no pain, excellent hemostasis and good wound 
healing with no postoperative complications and Er,Cr:YSGG laser caused minimal discomfort 
to patient, profuse bleeding during procedure and good healing outcome in treatment of oral 
leukoplakia. 
Conclusion: While comparing both the lasers, in this present study it has been concluded that 
Diode laser (940nm) is superior to that of Er,Cr:YSGG laser (2780nm) in treating oral 
leukoplakia. 
Key words: Diode laser, Er,Cr:YSGG laser, Oral leukoplakia. 
  
Introduction 
 
1 
 
              Oral leukoplakia is a predominantly white lesion of the oral mucosa 
that cannot be characterized as any other definable lesion.
1 
There is a dose – 
response relationship between tobacco usage and prevalence of oral 
leukoplakia.
2
 It is the most common potentially malignant lesion. Oral 
leukoplakia have been treated by surgical excision, cryotherapy, retinoids and 
other drugs.
2
 Laser therapy is a recent treatment modality which could be 
considered in the treatment of oral leukoplakia.
3 
              Laser is an acronym for Light Amplification by Stimulated 
Emission of Radiation which completely describes the whole physics by 
process of the generation of light.
4
  Dental lasers function by producing waves 
of photons (quanta of light) that are specific to each laser wavelength.
5 
This 
photonic absorption within the target tissue results in an intracellular and/or 
intercellular change to produce the desired result.
6
 Laser devices emit energy 
via chromatic radiation in either the visible, infrared or ultraviolet region of 
the spectrum. They produce in-phase waves and transmit heat and power when 
focused at close range.
7
 The most important characteristic is the wavelength of 
laser used, as the wavelength determines how the laser light will interact with 
the target tissue (absorption in the appropriate tissue chromophores, 
penetration depth into the tissue etc.) Other characteristics which also need to 
be considered include maximum power available to the user as the available 
power determines the number of procedures which can be done and the speed 
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with which they can be done, the way the laser beam can be modulated such as 
continuous wave or pulsed mode and the mode of delivery of the laser beam.
8 
      Dental lasers may be separated into two basic groups as soft lasers and 
hard lasers.
6 
They can be used both for diagnosis as well as therapeutic 
purpose. The superiority of lasers to other modalities is that they provide a 
blood free surgical field by sealing the blood vessels thereby offering excellent 
visibility and reduced operative time and minimize post operative swelling by 
sealing the lymphatic vessels.
9
 Lasers offer the ability to negotiate curves and 
fold in oral cavity and can vaporize, cut and coagulate tissue. With the use of 
lasers, the bacterial count is reduced, chances of mechanical trauma are 
minimal, scarring is negligible and pain is almost nil probably due to sealing 
of the nerve fibres.
9 
       Among the various soft tissue lasers that appeared in the mid 1990s, 
semiconductor Diode lasers also made their debut. With several advantages 
including their small size, price range and versatility regarding the possible 
treatment applications, the Diode lasers represent a valuable addition to the 
dentist's repertoire. Diode lasers can be used for a multitude of dental 
treatments which are predominantly soft tissue procedures and include soft 
tissue surgery, periodontal pocket therapy, management of peri-implantitis, 
etc. Diode laser can also be used for certain applications involving hard tissue 
(eg) root canal disinfection and laser-assisted tooth whitening.
8 
The available 
wavelength for dental use range from 800 nm to 980 nm. Each machine 
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delivers laser energy fibro optically in continuous wave and gated pulsed 
modes and is used in contact with soft tissue for surgery or out of contact for 
deeper coagulation. The Diode laser is an excellent soft tissue surgical laser 
and is indicated for cutting and coagulating oral mucosa.
10 
In 1997, Erbium laser which is a hard tissue laser was approved by 
FDI, for marketing in the United States. The Erbium laser has various uses, 
which can be divided into hard and soft tissue procedures for dentistry. 
Erbium lasers, by their sheer nature of being well absorbed by hydroxyapatite, 
were originally considered as primary hard tissue lasers. It must be 
remembered that the primary chromophore of the Erbium family of lasers is 
water in the target tissue, and the largest component of soft tissue is water. 
Laser physics and absorption curves of various tissues have shown that the 
Erbium family of lasers ablate soft tissue by the same mechanism as hard 
tissue. The laser energy from the infrared beam is converted into local thermal 
energy, and this energy creates a massive expansion in the target chromophore 
of water. The resulting microexplosions result in thin layers of tissue ablation. 
The erbium laser soft tissue removal process results in a ‘‘shaving’’ or 
‘‘planing’’ of the tissue that clinically appears different than the deeper 
penetrating ablation process seen with dedicated soft tissue lasers.
11
 
The Erbium family of dental lasers consist of two wavelengths with 
similar but not identical properties. The Erbium: Yttrium-Aluminium-Garnet 
(Er:YAG) laser produce a wavelength of 2940 nm and the Erbium, Chromium: 
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Yttrium-Scandium-Gallium-Garnet (Er,Cr:YSGG) laser produces a 
wavelength of 2780 nm.
12
 Er,Cr:YSGG laser is a solid state laser that emits 
at 2780 nm in the mid-infrared region, in the strongest absorption peak of 
water. This leads to a superior evaporative efficiency and minimal thermal 
injury to adjacent tissue compared with any other laser ideal for the removal of 
superficial skin layers with maximum sparing of adjacent structures, a short 
healing process and minimal adverse effects.
13 
Very few studies are done in evaluating the effectiveness of Diode 
laser and Er,Cr:YSGG laser in oral mucosal lesions. Hence, a study was 
proposed to compare the effectiveness of Diode laser and Er,Cr:YSGG laser in 
the treatment of oral leukoplakia. 
 
 Aims and objectives    
 
 
5 
 
 
 
AIM OF THE STUDY: 
To compare the effectiveness of Diode Laser and Er,Cr:YSGG Laser 
in treating oral leukoplakia. 
OBJECTIVES OF THE STUDY: 
1. To compare the effectiveness of Diode Laser and Er,Cr:YSGG Laser 
in treating oral leukoplakia.  
2. To assess bleeding during the Diode and Er,Cr:YSGG laser treatment. 
3. To assess pain using Behavioral Observation Pain Scale during the 
laser treatment. 
4. To assess pain using Visual Analogue Scale and “Faces” Pain Rating 
Scale immediately after the procedure and 7 days post- operatively. 
5. To observe the outcome of healing on the 7th, 14th and 21st post-
operative days after the treatment. 
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The present study is to Compare the effectiveness of Diode Laser and 
Er,Cr:YSGG Laser in the treatment of oral leukoplakia. To obtain a 
meaningful study and result, a proper and detailed review of the literature is of 
utmost importance.  The present literature review is about the various aspects 
of Lasers, Diode laser, Er,Cr:YSGG laser and comparison between diode and 
Er,Cr:YSGG laser in Oral leukoplakia. 
Diode Lasers:
 9,14,15
 
Diode lasers have a solid active medium, manufactured from 
semiconductor crystals using some combination of Aluminum, Gallium and 
Arsenide to change electric energy into light energy. The available 
wavelengths for dental use range from about 800 to 980nm placing them at the 
beginning of the near-infrared invisible nonionizing part of the spectrum. Each 
machine delivers laser energy fiber optically in continous mode and gated-
pulse modes, used ordinarily in contact with the tissue. The optic fiber needs 
to be cleaved and prepared before initial use and occasionally during long 
procedures to ensure the efficient operation of the laser.
14
  
All of the diode wavelengths are very well absorbed by pigmented 
tissue, although hemostasis is not quite as rapid as with the Argon laser. These 
lasers are relatively poorly absorbed by tooth structure so that soft tissue 
surgery can be performed safely in close proximity to enamel, dentin and 
cementum. The diode is an excellent soft tissue surgical laser indicated for 
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cutting and coagulating gingiva and mucosa and for soft tissue curettage or 
sulcular debridement.
15 
 Care must be taken when using the continuous emission mode because 
of the rapid thermal increase in the target tissue. The chief advantage of the 
diode lasers is use of a smaller size instrument. The units are portable and 
compact and are easily moved with minimum setup time.
9  
Basic design of Diode Laser: 
 One of the advantages of diode lasers in comparison to other laser 
systems, which is immediately apparent to the naked eye, is their size. The 
development of micro-structure diode cells which are capable of emitting laser 
light has drastically reduced the bulk of laser systems. The latest dental diode 
lasers have been designed to have dimensions similar to a standard phone.  
Only solid material active media (e.g. GaAlAs –Gallium Aluminium 
Arsenide) is used in diode lasers. Because of the crystalline nature of the 
active medium, the ends of the crystal can be selectively polished relative to 
internal refractive indices to produce totally and partially reflective surfaces 
thus serving the same function as the optical resonators of larger laser systems. 
The discharge of current across the active medium releases photons from the 
active medium, finally resulting in the generation of laser light of a specific 
wavelength, which is determined by the active medium used. At the present, 
each diode "chip" produces relatively low-energy output. Some low power 
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diode lasers, operating in milliwatt range, are usually being used for low level 
laser therapy (LLLT). In order to achieve the power necessary for various 
dental procedures (e.g. soft tissue surgery), today's dental diode lasers employ 
banks of individual diode chips in parallel to achieve the appropriate power 
levels (several watts).
8
  
Laser light emission modes:  
 Lasers are said to be running in either continuous wave (CW) or pulsed 
mode. This relates to the rate of emission of laser light with time and the prime 
benefit of a pulsed mode will be the capacity of the target tissue to cool 
between successive pulses. The CW mode is generally the fastest way to 
ablate tissues but heat can build up and cause collateral damage to the target 
and adjacent tissues. Modern dental diode lasers can operate in both CW and 
pulsed mode. The factors that determine the average power when the diode 
laser is operating in pulsed mode are the current power setting and the duty 
cycle setting. Duty cycle is a periodic phenomenon defined as the ratio of the 
duration of the phenomenon (pulse width) in a given period to the period 
(reciprocal value of the current frequency setting - number of pulses per 
second).
8 
 It is important to familiarize oneself with the various average and peak 
powers that can be achieved when using different emission mode settings of 
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the laser system in order to achieve an optimal transfer of the energy from the 
laser beam to the target tissue, resulting in a desired therapeutic effect.
8 
Laser light Delivery to the Target Tissue: 
 Most dental diode lasers employ a flexible optic fibre (usually inserted 
into an appropriate handpiece for comfortable handling) to deliver the 
treatment beam to the desired area. Using a smaller diameter fibre will 
increase the power density at the fibre tip. As a result, the power setting must 
be decreased. Increasing the power may be required when using a larger 
diameter fibre. As a rule of thumb, in order to achieve the same rate of work 
after changing fibre diameters, a smaller diameter fibre will require less power 
and conversely, a larger diameter will require more power. Another thing to 
keep in mind is the speed of movement of the fibre tip during treatment. 
Tissue charring is an undesirable side effect of too much power and/or the tip 
moving too slowly. Least amount of power is necessary to complete the 
procedure and move the fibre tip using short 1-2 mm "paint brush" type 
strokes and move quickly when working on soft tissue. The condition of the 
optical fibre must be checked regularly. The tip should be cleaved regularly 
after it becomes blackened (2-4 mm from the tip), because tissue debris 
accumulate on the tip during surgery and this causes the fibre tip to retain 
extreme heat and begins to act as a "branding iron". This can lead to unwanted 
tissue heating and can lead to rapid tip deterioration and subsequent breakage. 
It is also important to properly cleave the fibre so that no shard is present on 
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the fibre tip, as it may act as a miniature scalpel and damage the small blood 
vessels, thus interfering with hemostasis and coagulation.
8 
Applications:  
 The removal of fibroma, labial and lingual frenectomies, small 
hemangiomata, mucocele, denture granulomata, treatment of nonerosive 
lichen planus, aphthae, herpes lesions, premalignant lesions like leukoplakia.
8
 
Erbium family Lasers (Er,Cr:YSGG and Er:YAG):
 
 
There are two distinct wavelengths with similar properties that use 
Erbium. Firstly, Er,Cr:YSGG (2790nm) has an active medium of a solid 
crystal of Yttrium-Scandium-Gallium-Garnet that is doped with Erbium and 
Chromium and Er:YAG (2940nm) has an active medium of a solid crystal of 
Yttrium-Aluminum-Garnet that is doped with Erbium. Both of these 
wavelengths are near the boundary of the near-infrared and mid-infrared, 
invisible, and nonionizing portion of the spectrum. Both of these lasers are 
delivered fiber optically in the free-running pulsed mode. At the end of the 
fiber, a hand piece and small-diameter glass tips concentrate the laser energy 
down to a convenient surgical size, approximately 0.5nm. These two 
wavelengths have the highest absorption in water of any dental wavelength 
and have a high affinity for hydroxyapatite.
9,14,15
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Er,Cr:YSGG laser emits energy at a wavelength of 2780 nm and 
delivers photons into air-water spray matrix producing microexplosive forces 
on water droplets. It is a hydrokinetic system laser with a frequency of 20 Hz, 
pulse energy between 0 and 300 mJ, a focal distance of approximately 1.5 mm 
from the tissue and has FDA approval for several soft tissue procedures. The 
water droplets of the water spray are energized by laser energy 1.5 mm from 
the end of the tip; thus, the most focused distance while working with this 
laser is 1.5 mm from the tissue so that less thermal damage occurs. It is a very 
precise ablation instrument that offers certain advantages. It is strongly 
absorbed by water and causes minimal damage to the adjacent tissues, 
especially the underlying muscle layers. Due to minimal trauma to the 
adjacent tissues, postoperative healing was favorable, with very little scar 
formation. Post operative bleeding is minimal.
9,14,15
 
Review of Laser: 
 Townes et al (1958)
16
 examined the Maser principles, which were 
eventually used for the conversion of light energy using light from visible and 
infrared portions of electromagnetic spectrum. This examination introduced 
the principles of light amplification by the stimulated emission radiation or 
laser.
 
 Theodore Maimen (1960)
10
 successfully stimulated ruby crystals to 
produce red light with a wavelength of 0.69 nm, thus first laser was developed. 
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Within a year the ophthalmologist used this device for photocoagulation. 
Snitzer (1961)
10
 developed the second laser which was Neodymium laser.
 
 Ralph H Stern et al (1964)
10
 started research on dental laser at the 
University of California at Los Angeles, School of Dentistry and reported the 
development of cratering and glasslike fusion of enamel and the penetration 
and charring of dentin following a single millisecond pulse of ruby laser at 
500 to 2000 J/cm
2
. 
 Townes, Basov and Prokhrov (1964)
17
 were awarded the Nobel Prize 
for the development of laser. Bridges (1964)
18
 and Geusic (1964)
18
 developed 
continuous wave Argon laser and Nd:YAG laser respectively.
 
This continuous 
wave 488 nm (blue-green) gas laser was easy to control and its high 
absorption by haemoglobin made it well suited to retinal surgery; clinical 
systems for treatment of retinal diseases were soon available. 
 Taylor et al (1965)
18
 were first to report the histologic effects of the 
ruby laser on the dental pulp. They observed extensive hemorrhagic necrosis 
and disruption of odontoblastic layer in the incisors of laboratory animals, 
which have been exposed to a 3-millisecond pulse of a ruby laser ranging 35 
to 55J. Damage to adjacent teeth and surrounding structures were also reported 
as a result of scattering of laser beam.
 
 Dr Leon Goldman (1965)
15
 a dermatologist was first to report the use 
of laser on a vital human tooth. While experimenting with tattoo removal 
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using ruby laser he focused two pulses of red light on a tooth of his dentist 
brother which resulted in painless crazing of the enamel.
 
Thus, the first laser 
dentist was a physician and the first laser patient was a dentist. 
 Polanyi (1965)
16
 was first to perform a surgical procedure by carbon 
dioxide laser. Yahr and Scully (1966)
16
 identified and documented specific 
cutting and hemostatic properties of continuously operating carbon dioxide 
laser beam.
 
 Adrian (1971)
9
 confirmed extensive pulpal injury and destruction with 
ruby laser even at greatly reduced power levels.
 
           Stern (1974)
9
 observed that under specific parameters of exposure to 
the ruby laser there occurred an increased resistance to the acid penetration 
into enamel, suggesting a possible role for the laser in caries prevention. 
 Yamamoto et al (1974)
9
 from Tohoku University School of Dentistry 
was first to report the dental application of Neodymium laser to vital oral 
tissue in experimental animals. In a series of experiments, they determined 
that Nd:YAG laser was an effective tool for inhibiting the formation of an 
incipient caries both in vitro and in vivo.
 
 Shafir (1977)
16
 a plastic and reconstructive surgeon became first one 
to apply laser in oral maxillofacial surgery by excising buccal hemangioma in 
an 8 year old boy.
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 In the early 1980s, smaller but more powerful lasers became available. 
Most of these systems were CO2 lasers used for cutting and vaporizing tissue 
and argon lasers for ophthalmic use. These ‘second generation’ lasers were all 
continuous wave systems which
 
tend to cause non-selective heat injury, and
 
proper use required a long ‘learning curve’ and experienced laser surgeons. 
 Dr Terry Myers and Dr. William (1980’s)9 an ophthalmologist 
conducted experiments to remove incipient caries. Soon after this the 
development of true dental laser begun. D-lase 300 was the first true dental 
laser system designed specifically for dental application. 
 Melcer et al (1984)
9
 actively involved in the clinical application of the 
carbon dioxide laser for the vaporization of caries, reported the successful 
treatment of over 1,000 patients in clinical trials of caries removal. 
 Frame and Fisher (1984)
19
 of England presented several papers on 
treatment of benign and premalignant oral lesions using carbon dioxide laser.
 
 Frame, Pecaro and Pick (1985)
15 
were first to use carbon dioxide 
laser to oral soft tissue lesions and periodontal procedures.
 
Melcer et al 
(1987)
15
 further concluded that carbon dioxide laser could induce secondary 
dentin formation and sterilization of dentin and exposed pulp. 
 The Food and Drug Administration (1987)
17,20
 gave the marketing 
approval for laser use in oral surgery to Pfizer Laser Company for 10W 
  
Review of Literature 
 
 
 
15 
 
portable carbon dioxide laser system. In 1989, after the market clearances 
were approved by the Medical Device Division of Food and Drug 
Administration in United States, groups of laser dentists joined together to 
form local study clubs, societies and diverse organizations for the purpose of 
gathering and sharing information related to their use. Another major 
advancement was the introduction of scanning devices in the early 1990s, 
enabling precision computerized control of laser beams. Scanned, pulsed 
lasers revolutionized the practice of plastic and cosmetic surgery by making 
safe, consistent laser re-surfacing possible, as well as increasing public 
awareness of laser medicine and surgery.
 
Laser used in the treatment of Oral leukoplakia: 
 Fausto Chiesa et al (1986)
21
 treated 92 leukoplakias by CO2 laser 
surgery the results concluded that minimal damage, immediate hemostasis and 
good wound healing was seen. 
  Felix WK Chu et al (1988)
22 
used CO2 laser to treat 29 leukoplakia 
patients and follow up was done for 3-10 years. The results supported CO2 
laser over conventional modes of treatment in relation to precision of tissue 
removal, minimal damage to adjacent tissue, immediate hemostatic effect, 
excellent wound healing and effective destruction of abnormal mucosal tissue 
minimizing recurrences. 
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 Roodenberg JLN et al (1991)
23  
treated a total of 70 patients with 103 
leukoplakias with CO2 laser evaporation. They concluded that there was an 
excellent wound healing with virtually no scarring. The patients were followed 
up during a period of upto 12 years (mean 5.3 years) showing a cure rate of 
90%. 
 Gooris et al (1999)
24
 conducted a retrospective study to evaluate the 
treatment results of CO2 laser evaporation for 27 cases of leukoplakia of the 
lip. It was concluded that selective removal of affected epithelium with 
minimal damage to surrounding structures is possible using CO2 laser 
evaporation, followed by excellent wound healing and good functional result. 
Treatment can be performed under local anaesthesia on an outpatient basis and 
the recurrence rate is low compared with the recurrence rate after surgical 
excision.
 
 PS van der Hem et al (2005)
25
 treated 200 patients of oral leukoplakia 
by CO2 laser evaporation from 1976-2004. In a follow up period of 1–219 
months, 89% treated leukoplakia did not show a recurrence. Thus the study 
with a long follow up showed that laser is a good prophylactic treatment for 
oral leukoplakia. 
 Vasavi Krishnamurthy et al (2009),
26 
Tousif Farid Sayed et al 
(2009)
53 
in the treatment of oral leukoplakia which have shown excellent 
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wound healing, immediate hemostatic effect and minimal tissue damage with 
minimal recurrence rate. 
Review of Diode laser in Soft tissue lesions: 
 George Romanos et al (1999)
27
 in their  study examined the wound 
healing of soft tissue after the application of a diode laser (980 nm) in oral 
surgical procedures in 22 patients which comprised of removal of soft tissue 
tumors, frenectomies, excision of gingival hyperplasias, vestibuloplasties, 
hemangioma removal, and peri implant soft tissue surgery. The laser was used 
in both pulsed and continuous modes, with and without contact to the tissue. It 
was concluded that diode laser resulted in sufficient hemostasis and precise 
incision margin with all of the surgical procedures. The coagulation properties, 
were beneficial in vascular lesions. The postoperative advantages, i.e., lack of 
swelling, bleeding, pain or scar tissue formation and good wound healing were 
observed in all the applications and depended on the laser physical parameters.
 
 Goharkhay et al (1999)
28
 used diode laser with 810 nm wavelength 
on soft tissue lesions which resulted in excellent coagulation ability. 
 Mona Soliman et al (2005)
29
 treated 25 patients suffering from 
persistent oral lichen planus with diode laser (980 nm) at the affected areas of 
oral mucous membrane with defocused mode until blanching of the treated 
area. No serious complications were recorded, apart from slight edema and 
pain. Complete healing occurred after the second week. Diode laser provides a 
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marked clinical improvement without the need for neither local nor systemic 
treatment.
 
 Deppe, H. and H.H. Horch (2007)
3
 reviewed the use of diode laser 
systems for the treatment of oral and maxillofacial diseases as an application 
in removal of premalignant lesions of the oral mucosa concluded its use did 
not cause discomfort to the patient, minimal bleeding and excellent wound 
healing. 
 Jawahar R et al (2009)
30
 used diode laser to treat trismus in oral 
submucous fibrosis patients. They concluded that Diode laser is a less 
expensive and alternative method in group III and group IVA cases in whom 
bilateral temporalis myotomy and coronoidectomy are considered to be the 
only solution. Also this technique had less morbidity and was suitable for 
Asian population as it required less hospital stay and less follow up as 
compared to other surgical methods.
 
 Apollonia Desiate et al (2009)
31
 evaluated the safety and efficacy of a 
980nm diode laser for  the treatment of benign facial pigmented and vascular 
lesions in 20 patients which resulted in healing within 10 days. The melanoses 
healed completely within four weeks. All the vascular lesions healed after 15 
days without any residual scarring thus concluding that patient undergoing 
treatment with diode laser have good acceptance without compromising the 
health of the patient. 
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 Akmam H. AI-Mahdi (2010)
32
 evaluated the efficiency of diode 
Laser 810 ± 20nm in treatment of oral lesions in 6 patients (2 females and 4 
males) different oral lesions were treated in the hospital of specialized 
surgeries by the use of diode laser 810 nm, the lesions were: Apthous, Lichen 
planus, Pyogenic granuloma, Second stage of implant. The results showed that 
there was no pain, no bleeding, and no infection while the edema and necrosis 
at the operation site were present. They concluded that Diode laser can be used 
to perform haemostatic surgery, decrease rate of infection and reduce post 
operative discomfort.
 
 Pedron IG et al (2010)
17
 used diode laser in excision of mucocele 
which resulted in no post operative problems. 
 
            Prajwalit Kende et al (2011)
33
 in their case report concluded diode 
laser as a promising aid in performing excisional biopsies of oral premalignant 
lesions in patients who need to be treated with a technique where reduction of 
the operative and postoperative blood loss, postoperative discomfort is 
important with minimal problems in the histopathological evaluation.
 
 Nilesh Ravel et al (2011)
34 
conducted a clinical study on post 
operative recovery, depth control and wound healing  of diode laser on white 
lesions using the visual analogue scale for pain. Out of 10 patients, (20%) 
complained of moderate pain during first three days following laser 
irradiation, while rest of the patient complained mild pain (80%). The pain 
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disappeared in the end of third week post operatively. Complete wound 
healing and depth control was seen using Diode laser. 
Review of Er,Cr:YSGG laser in Oral soft tissue lesions: 
 Rizolu et al (1996)
35
 conducted a study on 12 mucocutaneous soft 
tissues using Er,Cr:YSGG laser which  resulted in minimal edge coagulation 
artifact, minimal hemorrhage, good re-epithelisation.  
 Lee SC (1998)
36
 in their study concluded that hemostatic ability is 
limited with the use of Er,Cr:YSGG laser because only the water on the 
surface of the blood in the surgical site is vaporized. There is neither deep 
penetration nor sustained heat to provide rapid vessel shrinkage. 
 Boj et al (2007)
20
 used Er,Cr:YSGG laser on squamous cell papilloma 
concluded that there was no pain medication required after surgery,wound 
healing was excellent and rapidly achieved with no recurrence. 
 Kirti chawla et al (2011)
37
  treated a 22 year old patient, diagnosed 
with lip mucocele with Er,Cr:YSGG laser which showed healing, which was 
uneventful, no analgesic required, no suture requires and no relapse was 
observed upto one year after surgery. 
 Chaudhary et al (2012)
38
 in their study  concluded that Er,Cr:YSGG 
Laser can be used effectively in the treatment of Oral Submucous fibrosis 
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which resulted in better mouth opening and no scar formation, with minimal 
discomfort to the patient.
 
Comparative studies using Diode laser and Er,Cr:YSGG laser:  
 Stabholz A et al (2003)
39
 in their study compared Diode and 
Er,Cr:YSGG laser and found that homeostasis is better achieved by the use of 
diode laser when compared to Er:Cr,YSGG Laser because diode lasers are 
very well absorbed in melanin and hemoglobin. There wavelengths (810-980 
nm) will pass through water and penetrate much deeper into the soft tissue 
unlike the Erbium laser were they are not well absorbed by these 
chromophores. They concluded that the Erbium family lasers is not ideal 
wavelength for soft tissue surgeries in which ideal homeostasis is desired. 
 Carcadillo- Ibarquren et al (2010)
40 
conducted an vitro study on 
porcine oral mucosa with CO2, Diode and Er,Cr:YSGG Laser to determine the 
thermal effect. The concluded that charring of tissue was minimal with 
Er,Cr:YSGG laser when compared to CO2 laser, whereas charring was more 
with Diode laser when compared to Er,Cr:YSGG laser. It was concluded that 
to minimize thermal effect on tissues, power density, continuous or pulse 
mode, the duration of pulse and pause interval must be adequate. 
 Jin et al (2010)
41
 conducted a comparative study to assess healing of 
buccal mucosa in 24 guines pig with stainless steel scalpel, Diode laser and 
Er,Cr:YSGG laser. It was found that Diode laser showed increased TGF beta 1 
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which determined at Diode laser has better effect on wound healing when 
compared to Er,Cr:YSGG laser. 
Comparative studies using laser in treatment of leukoplakia: 
 White et al (1998)
42
 compared CO2 with Nd:YAG laser in the 
management of oral mucosal lesion in an out- patient clinic treated over 80 
years period. The study included 64 patients with a variety of benign oral soft 
tissue lesions which were treated by laser excision.34 patients were treated by 
Nd:YAG contact laser and 29 patients by continous free- beam CO2 non 
contact laser. The largest group of lesion treated was leukoplakia which 
comprised 39 cases. The study concluded that both CO2 and Nd:YAG lasers 
are successful laser surgical options used for treatment of benign mucosal 
lesions and showed minimal post operative pain, conservative site specific 
invasive procedure and good wound healing. 
 Lim et al (2010)
43
 conducted a retrospective study in 35 patients 
diagnosed as leukoplakia to compare CO2 laser and Potassium – Titanyl 
phosphate to determine recurrence rate. The recurrence rate of lesion between 
2 groups were compared and they concluded that KTP laser resulted in lower 
recurrence rate than CO2 laser in treatment of leukoplakia.
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Fig.4: Diode laser equipment 
 
 
Fig.5: Er,Cr:YSGG laser equipment 
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Fig.6: Patient visiting OP  
 
 
 
 
Fig.7: White lesion present in the right buccal mucosa provisionally  
diagnosed as oral leukoplakia 
  
Figures 
  
 
 
 
Fig.8: Diode laser setting for Diode laser procedure 
 
 
Fig.9: Er,Cr:YSGG laser setting for Er,Cr:YSGG laser procedure 
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Fig.10: Initialization of Diode laser tip with carbon  
 
 
 
Fig.11: Laser incision done for biopsy using Diode laser 
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Fig.12: Site immediately after laser biopsy in posterior buccal mucosa 
 
 
 
Fig.13: Laser biopsy specimen sent for histopathological evaluation 
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Fig.14: Histoplathologically confirmed oral leukoplakia with mild  
dysplasia- 40x resolution 
 
 
 
Fig.15: One day wound healing after laser biopsy 
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Fig.16: Laser procedure done 
 
 
 
Fig.17: Diode laser used in anterior half and Er,Cr:YSGG laser procedure 
done in the posterior half of buccal mucosa showing no bleeding in anterior 
half and bleeding in posterior half- Immediately after laser procedure 
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Fig.18: One day after Diode laser and Er,Cr:YSGG laser procedure 
 
 
 
Fig.19: 7
th
 post- operative day wound healing 
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Fig.20: 14
th
 post-operative day wound healing 
 
 
 
Fig.21: 21
st
 post-operative day wound healing 
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The present study is a comparative study which was conducted in the 
Department of Oral Medicine and Radiology of Ragas Dental College and 
Hospital, Uthandi, Chennai and Smile Dental Clinic, T.Nagar, Chennai. It was 
devised to assess the effectiveness of Diode laser and Er,Cr:YSGG laser in the 
treatment of Oral leukoplakia, and to assess pain during the procedure and 7 
consecutive days after the procedure using three different pain rating scale. 
The data‟s obtained from the study were statistically analysed. Digital 
photographs were taken and visually analysed for bleeding during the 
procedure and wound healing on 7
th
, 14
th
 and 21
st
 day. The results extracted 
were compared with various variables included in the study and are presented 
here. 
Data Analysis obtained from Behavioral Observational Pain Rating Scale: 
 The Behavioral Observation Pain Rating Scale was used to 
determine pain in patient during Diode laser and Er,Cr:YSGG laser procedures 
separately in the treatment of oral leukoplakia. The categories used in the 
assessment of pain included face, leg, activity, cry and consolability.  
 In “Face” category: 
 „0‟was scored for no particular facial expression or smile or 
disinterested. „1‟ was scored for occasional grimace or frown, 
withdrawn. „2‟ was scored for frequent to constant frown, clenched 
jaw, quivering chin. 
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 In “Leg” category: 
 „0‟ was scored for relaxed position. „1‟ was scored if the 
patient‟s legs were uneasy, restless or tensed and „2‟ was scored if the 
patient kicked or drew his legs up. 
 In “Activity” category: 
 „0‟ was scored if the patient was lying quietly in normal 
position and moves easily. „1‟ was scored if the patient was squirming, 
shifting back and forth or tensed. „2‟ was scored if the patient was 
arched, rigid or jerking.  
 In „Cry‟ category: 
 „0‟ was scored for no crying. „1‟ was scored if the patient 
moaned, whimpered or occasionally complained and „2‟ was if the 
patient cried steadily, screamed, sobbed or frequently complained. 
 In “Consolability” category: 
 „0‟ was scored if the patient was contented and relaxed. „1‟was 
scored if the patient could be consoled when reassured by occasional 
touching, hugging or talking to and was distractable.„2‟ was scored 
when the patient was difficult to console or comfort. 
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Table 1: Comparison of „facial expression‟ in Behavioral Observation Pain 
Rating Scale between Diode and Er,Cr:YSGG laser: 
 During the treatment of Oral leukoplakia with Diode laser it was 
observed that out of 5(100%) patients, 3(60%) patients had no facial 
expression or smile, whereas 1(20%) patient occasionally frowned and 
withdrew and constant frown, clenched jaw and quivering chin was observed 
in 1(20%) patient. During Er,Cr:YSGG laser procedure on oral leukoplakia it 
was noted that, out of 5(100%) patients, 4(80%) patients occasionally frowned 
and withdrew and 1(20%) patient had frequent to constant frown, clenched 
jaw and quivering chin . 
           On comparing the facial expression of patients during Diode and 
Er,Cr:YSGG laser procedure the results were insignificant with a p- value of 
0.082. 
Table 2: Comparison of „leg movement‟ in Behavioral Observation Pain 
Rating Scale between Diode and Er,Cr:YSGG laser: 
 It was observed that during Diode laser Procedure, out of 5(100%) 
patients, 3(60%) patients had their legs relaxed, whereas 1(20%) patient had 
uneasy, restless and tensed legs and 1(20%) patient was kicking during the 
Diode procedure and legs were drawn up. During Er,Cr:YSGG laser 
procedure, it was noticed that 4(80%) patients out of 5(100%) patients had 
 Results 
 
 
40 
 
uneasy, restless and tensed leg and 1(20%) patient legs were drawn up as well 
as kicking during the procedure. 
          On comparing the leg movements of patients during the Diode and 
Er,Cr:YSGG laser procedure it was noted that no significant difference was 
found with a p- value of 0.082. 
Table 3: Comparison of „activity‟ of patients during Diode and Er,Cr:YSGG 
laser procedures in Behavioral Observation Pain Rating Scale: 
 Out of 5(100%) patients, it was observed that during Diode laser 
procedure 4(80%) of patients were lying quietly in normal position and moved 
easily, whereas 1(20%) patient was arched, rigid and jerking. During 
Er,Cr:YSGG laser procedure it was observed that out of 5(100%) patients, 
1(20%) patient was lying quietly, 3(60%) patients were tensed, whereas 
1(20%) patient was arched, rigid and jerking. 
 On comparing the activity of patients during Diode and Er,Cr:YSGG 
laser procedure, no significance with a p- value of 0.082. 
Table 4: Comparison of „cry‟ of patient in Behavioral Observation Pain 
Rating Scale in between Diode and Er,Cr:YSGG laser: 
 During the treatment of Oral leukoplakia with Diode laser it was 
observed that out of 5(100%) patients 4(80%) patients did not cry, whereas 
1(20%) patient was crying steadily, screamed and frequently complained. 
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During Er,Cr:YSGG laser procedure on oral leukoplakia it was noted that, out 
of 5(100%) patients, 2(40%) patients did not cry, 2(40%) patients moaned or 
whimpered and occasionally complained and 1(20%) patient was crying 
steadily, screamed and frequently complained during the procedure. 
           On comparing the cry of patients during Diode and Er,Cr:YSGG laser 
procedure the results were insignificant with a p- value of 0.082. 
Table 5: Comparison of „consolability‟ in Behavioral Observation Pain Rating 
Scale in between Diode and Er,Cr:YSGG laser: 
 During the treatment of Oral leukoplakia with Diode laser it was 
observed that out of 5(100%) patients, 4(80%) patients were content and 
relaxed, whereas 1(20%) patient was very difficult to console or comfort. 
During Er,Cr:YSGG laser procedure on oral leukoplakia it was noted that, out 
of 5(100%) patients, 2(40%) patients were content and relaxed, 2(40%) 
patients had to be reassured occasionally by touching or talking and were 
distractable and 1(20%)  patient was difficult to console or comfort. 
           On comparing consolability during Diode and Er,Cr:YSGG laser 
procedure the results were insignificant with a p- value of 0.082. 
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Table 6: Data analysis of Diode laser and Er,Cr:YSGG laser obtained by the 
use of Behavioral Observation  Pain Rating Scale: 
 On comparing results obtained from Behavioral Pain Rating Scale 
from Diode laser and Er,Cr:YSGG laser, it was observed that for the five 
patients the mean value obtained was 2.40 for Diode laser and 5.00 for 
Er,Cr:YSGG laser with a standard deviation of 4.336 for Diode laser and 
3.082 for Er,Cr:YSGG laser. Data analysis of Diode laser and Er,Cr:YSGG 
laser obtained by the use of Behavioral Observation Pain Rating Scale yielded 
insignificant result with a p – value of 0.061. 
Data analysis of “Faces” pain rating scale: 
 The “Faces” Pain Rating Scale is a diagrammatic representation of 
the pain experienced by the patient. The patients were assessed immediately 
after the surgery for pain. The patients were called for all the seven post 
operative days right from the next day after treatment to the 7
th
 day. The 
emotion icons expressed were then correlated to a scale which is divided into 
six scores ranging from 0-5. 
 „0‟ representing no hurt. 
 „1‟ representing hurts little bit. 
 „2‟ representing hurts little more.  
 „3‟ representing hurts even more. 
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 „4‟ representing hurts whole lot.  
 „5‟ representing hurts worst.  
 The scores were entered into the case sheet proforma for each case for 
both the Diode and Er,Cr:YSGG on the day of treatment and 7 post-operative 
days following the day of treatment. 
Table 7: Comparison of pain immediately after the procedure between Diode 
laser and Er,Cr:YSGG laser using „Faces‟ Pain Rating Scale: 
 Immediately after the Diode laser procedure out of 5(100%) patients 
it was observed that  in 3(60%) patients experienced no hurt, in 1(20%) 
patient, had hurt little bit whereas 1(20%) patient, the procedure hurted worse 
which was denoted by emotion icon and then correlated with scale. And 
immediately after Er,Cr:YSGG laser  procedure it was observed 1(20%) 
patient had hurt little bit, 3(60%) patients hurt little more, and 1(20%) 
experienced worst hurt which was denoted by emotion icon and then 
correlated with scale. On comparing the pain observed immediately between 
the Diode and Er,Cr:YSGG laser procedure using „Faces‟ Pain Rating Scale  
insignificant result was yielded with a p- value of 0.235. 
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Table 8: Comparison of pain on the 1
st
 post-operative day following the day 
of the treatment between Diode laser and Er,Cr:YSGG laser procedure using 
„Faces‟ Pain Rating Scale: 
 On “1st post-operative  day”, after the Diode laser procedure out of 
5(100%) patients it was observed that 3(60%) patients experienced no hurt, 
1(20%) patient experienced  hurt little bit denoted by emotion icon whereas  in 
1(20%) patient the procedure hurted whole lot. And after Er,Cr:YSGG laser  
procedure on the 1
st
 post-operative day it was observed  that in 4(80%) 
patients had experienced little bit hurt and 1(20%) experienced hurt whole lot 
denoted by emotion icon. On comparing the pain observed on the 1
st
 post-
operative day between Diode and Er,Cr:YSGG laser procedure using „Faces‟ 
Pain Rating Scale yielded insignificant result with a p- value of 0.082. 
Table 9: Comparison of pain on the 2
nd
 post-operative day following the day 
of treatment between Diode laser and Er,Cr:YSGG laser procedure using 
„Faces‟ Pain Rating Scale: 
 On “2nd post-operative day”, after the Diode laser procedure out of 
5(100%) patients it was observed that 4(80%) patients experienced no hurt, 
whereas 1(20%) patient denoted the emotion icon “hurts even more”. And 
after Er,Cr:YSGG laser  procedure on the 2
nd
 post-operative day it was 
observed  that in 4(80%) patients had experienced no hurt and 1(20%) 
experienced hurt even more which was denoted by emotion icon correlated 
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with a scale. On comparing the pain observed on the 2
nd
 post-operative day 
between Diode and Er,Cr:YSGG laser procedure using „Faces‟ Pain Rating 
Scale yielded significant result with a p- value of 0.025. 
Table 10: Comparison of pain on the 3
rd
 post-operative day following the day 
of treatment between Diode laser and Er,Cr:YSGG laser procedure using 
„Faces‟ Pain Rating Scale: 
 On “3rd post-operative day”, after the Diode laser procedure out of 
5(100%) patients it was observed that 4(80%) patients experienced no hurt, 
whereas 1(20%) patient denoted the emotion icon “hurt little more”. And  on 
the 3
rd
 post-operative day after Er,Cr:YSGG laser it was observed  that  
4(80%) patients had experienced no hurt and 1(20%) experienced hurt little  
more which was denoted by emotion icon. On comparing the pain observed on 
3
rd
 post operative day between Diode and Er,Cr:YSGG laser procedure using 
„Faces‟ Pain Rating Scale yielded significant result with a p- value of 0.025. 
Table 11: Comparison of pain on the 4
th
 post- operative day following the day 
of treatment between Diode laser and Er,Cr:YSGG laser procedure using 
„Faces‟ Pain Rating Scale: 
 On “4th post-operative day”, after the Diode laser procedure out of 
5(100%) patients it was observed that 4(80%) patients experienced no hurt, 
whereas 1(20%) patient experienced hurt little bit. And after Er,Cr:YSGG 
laser  procedure on the 4
th
 post operative  day it was observed  that  4(80%) 
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patients had experienced no hurt and 1(20%) experienced hurt little bit which 
was denoted by emotion icon. On comparing the pain observed on 4
th
 post-
operative day between Diode and Er,Cr:YSGG laser procedure using „Faces‟ 
Pain Rating Scale yielded significant result with a p- value of 0.025. 
Table 12: Comparison of pain on the 5
th
, 6
th
 and 7
th
 post-operative days 
following the day of treatment between Diode laser and Er,Cr:YSGG laser 
procedure using „Faces‟ Pain Rating Scale: 
 On “5th, 6th and 7th post-operative days”, all 5(100%) patients 
experienced no hurt, in the areas treated with Diode and Er,Cr:YSGG laser. 
On comparing the pain observed on 5
th
, 6
th
 and 7
th
 day after Diode and 
Er,Cr:YSGG laser procedure using „Faces‟ Pain Rating Scale yielded result 
with a p- value which is constant, which is not significant. 
Table 13: Data analysis of Diode laser and Er,Cr:YSGG laser obtained by the 
use of „Faces‟ Pain Rating Scale: 
 On comparing results obtained from „Faces‟ Pain Rating Scale from 
Diode laser and Er,Cr:YSGG laser immediately after laser procedure and  7
 
days post-operatively, it was observed that for five patients the mean value 
obtained was 3.40 for diode laser and 5.20 for Er,Cr:YSGG, laser with a 
standard deviation of 6.542 for Diode laser and 5.495 for Er,Cr:YSGG laser. 
Data analysis of Diode laser and Er,Cr:YSGG laser obtained by the use of 
„Faces‟ Pain Rating Scale yielded significant result with a p – value of 0.001. 
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Table 14: „Faces‟ Pain Rating Scale in Diode and Er,Cr:YSGG laser 
immediately after the procedure and 7 post-operative days: 
 Data analysis was done for Diode laser and Er,Cr:YSGG laser 
separately ranging from the day of procedure immediately after the laser 
procedure and 7 post-operative days to assess pain experienced in „Faces‟ Pain 
Rating Scale, with Diode laser procedure, the mean rank was 5.80 
immediately after treatment, 5.60 on the 1
st
 post-operative day, 4.60 on the 2
nd
 
post- operative day, 4.40 on the 3
rd
 post-operative day, 4.20 on the 4
th
 post-
operative day, 3.80 on the 5
th
, 6
th 
and 7
th
 post-operative day.  
 With the Er,Cr;YSGG laser procedure the mean rank was 7.90 
immediately after treatment, 7.10 on the 1
st
 post-operative day, 4.00 on the 2
nd
 
post-operative day, 3.80 on the 3
rd
 post-operative day, 3.60 on the 4
th
 post-
operative day and 3.20 on 5
th
, 6
th
 and 7
th
 post-operative day with Er,Cr:YSGG 
laser procedure. 
 Analysis yielded insignificant results in „Faces‟ Pain Rating Scale 
with a p-value of 0.093 with Diode laser and  yielded highly significant result 
in „Faces Pain Rating Scale with p- value of 0.000 with Er,Cr:YSGG laser. 
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Data analysis of Visual analogue scale: 
 The Visual Analogue Scale was used to assess pain which was 
experienced by the patient immediately after the procedure and for the 7
 
post 
operative days following the day of treatment by visually scoring pain with a 
scale ranging from 0 to 10. The patient was asked to score the experience of 
pain with “0” denoting no pain, “5” denoting distressing pain “10” denoting 
unbearable pain and if the patient experienced pain between these ranges 
denoted by respected numbers from 1- 4, 6 - 9. And the scores were entered 
into the case sheet proforma. 
Table 15: Comparison of pain immediately after the procedure between Diode 
laser and Er,Cr:YSGG laser using Visual Analogue Scale: 
 Immediately after the Diode laser procedure, 2(40%) patients scored 
„0‟ on visual analogue scale, 2(40%) patients scored „1‟ on the scale and 
1(20%) patient scored „10‟ on the scale. After the Er,Cr:YSGG laser 
procedure 3(60%) patients scored „3‟ on visual analogue scale,1(20%) patients 
scored „1‟ on the scale and 1(20%) patient scored „10‟ on the scale with 
Er,Cr:YSGG laser.  
 On comparing the pain observed immediately after the Diode and 
Er,Cr:YSGG laser procedure using Visual Analogue Scale yielded 
insignificant result with a p- value of 0.155. 
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Table 16: Comparison of pain on the
 
1
st
 post-operative day following the day 
of treatment between Diode laser and Er,Cr:YSGG laser post operatively 
using Visual Analogue Scale: 
 On 1
st
 post-operative day, 3(60%) patients scored „0‟ on visual 
analogue scale, 1(20%) patient scored „1‟ on the scale and 1(20%) patient 
scored „8‟ on the scale with the use of Diode laser. After Er, Cr:YSGG laser, 
3(60%) patient scored „2‟ on visual analogue scale, 1(20%) patient scored „3‟ 
on the scale and 1(20%) patient scored „8‟ on the scale.  
 On comparing the pain on 1
st
 post-operative day after Diode and 
Er,Cr:YSGG laser procedure using Visual Analogue Scale yielded significant 
result with a p- value of 0.040. 
Table 17: Comparison of pain on the
 
2
nd
 post-operative day following the day 
of treatment between Diode laser and Er,Cr:YSGG laser post operatively 
using Visual Analogue Scale: 
 On 2
nd
 post-operative day, 4(80%) patients scored „0‟ on visual 
analogue scale, 1(20%) patient scored „5‟ on the scale with the use of Diode 
laser. It was observed that 4(80%) patients scored „1‟ on visual analogue scale, 
1(20%) patient scored „6‟ on the scale with Er,Cr:YSGG laser.   
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 On comparing the pain on 2
nd 
post operative day after Diode and 
Er,Cr:YSGG laser procedure using Visual Analogue Scale yielded significant 
result with a p- value of 0.025. 
Table 18: Comparison of pain on the
 
3
rd
 post-operative day following the day 
of treatment between Diode laser and Er,Cr:YSGG laser post operatively 
using Visual Analogue Scale: 
 On 3
rd
 post-operative day, 4(80%) patients scored „0‟ on visual 
analogue scale, 1(20%) patient scored „4‟ on the scale with the use of Diode 
laser. It was noted that 4(80%) patients scored „0‟ on visual analogue scale, 
1(20%) patient scored „4‟ on the scale with Er,Cr:YSGG laser.   
 On comparing the pain on 3
rd
 post-operative day after Diode and 
Er,Cr:YSGG laser procedure using Visual Analogue Scale yielded significant 
result with a p- value of 0.025. 
Table 19: Comparison of pain on the
 
4
th
 post-operative day following the day 
of treatment between Diode laser and Er,Cr:YSGG laser post operatively 
using Visual Analogue Scale: 
 On 4
th
 post-operative day, 4(80%) patients scored „0‟ on visual 
analogue scale, 1(20%) patient scored „3‟ on the scale with the use of Diode 
laser. It was noted that 4(80%) patients scored „0‟ on visual analogue scale, 
1(20%) patient scored „3‟ on the scale with Er,Cr:YSGG laser.   
 Results 
 
 
51 
 
 On comparing the pain on 4
th
 post-operative day after Diode and 
Er,Cr:YSGG laser procedure using Visual Analogue Scale yielded significant 
result with a p- value of 0.025 
Table 20: Comparison of pain on the 5
th
,
 
6
th
 and 7
th
 post-operative days 
following the day of treatment between Diode laser and Er,Cr:YSGG laser 
post operatively using Visual Analogue Scale: 
 On 5
th
, 6
th
 day & 7 post-operative days”, 5 (100%) patients scored 
„0‟ on the visual analogue scale with both Diode and Er,Cr:YSGG laser. On 
comparing the pain observed on 5
th
, 6
th
 and 7
th
 post-operative days after Diode 
and Er,Cr:YSGG laser procedure using Visual Analogue Scale yielded result 
with a p- value which is constant which denotes no significant. 
Table 21: Data analysis of Diode laser and Er,Cr:YSGG laser obtained by the 
use of Visual Analogue Scale: 
 On comparing results obtained from Visual Analogue Scale from 
Diode laser and Er,Cr:YSGG laser immediately after laser procedure and 7
 
post-operative days, it was observed that for  five patients the mean value 
obtained was 6.60 with Diode laser and 11.40 for Er,Cr:YSGG laser with a 
standard deviation of 13.107  for Diode laser and 10.991  for Er,Cr:YSGG 
laser. Data analysis of Diode laser and Er,Cr:YSGG laser obtained by the use 
of Visual Analogue Scale yielded highly significant result with a                        
p – value of 0.000. 
 Results 
 
 
52 
 
Table 22: Visual Analogue Scale in Diode and Er,Cr:YSGG laser 
immediately after the procedure and 7
 
post-operative days: 
 Data analysis was done for Diode laser and Er,Cr:YSGG laser 
separately ranging from the day immediately after the laser procedure to 7
 
post-operative days to assess pain by Visual Analogue Scale.  
 With Diode laser, the mean rank was 6.50 immediately after treatment, 
5.50 on the 1
st
 post-operative day, 4.40 on the 2
nd
 post-operative day, 4.30 on 
the 3
rd
 post-operative day, 4.10 on the 4
th
 post-operative day, 3.70 on the 5
th
, 
6
th 
and 7
th
 post-operative days.  
 With Er,Cr:YSGG laser, the mean rank was 8.00 immediately after 
treatment, 7.00 on the 1
st
 post-operative day, 6.00 on the 2
nd
 post-operative 
day, 3.40 on the 3
rd
 post-operative day, 3.20 on the 4
th
 post-operative day, 2.80 
on the 5
th
, 6
th 
and 7
th
 post-operative days.  
 Analysis yielded significant results in Visual Analogue Scale with a          
p-value of 0.025 with Diode laser and yielded highly significant result in 
Visual Analogue Scale with p- value of 0.000 with Er,Cr:YSGG laser. 
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Digital photographs analysed by visual method to analysed the bleeding 
during procedure and outcome of wound healing on 7
th
, 14
th
 and 21
st
 post-
operative day: 
 Digital photographs were taken pre - laser therapy, during the laser 
therapy to analysed bleeding and post laser therapy. The photographs were 
taken during the 7
th
, 14
th
 and the 21
st
 post- operative day to analyze healing 
outcome of the patient treated with Diode laser and Er,Cr:YSGG laser.  
Table 23: Comparison of Bleeding during the procedure between Diode and 
Er,Cr:YSGG laser: 
 During the Diode laser therapy on the anterior half of the lesion which 
was divided with the reference point with a marker between the premolars, all 
5(100%) patients had minimal bleeding during ablation with occasional 
wiping of the area with the cotton roll to achieve hemostasis and it was           
scored „1‟. 
 During Er,Cr:YSGG laser therapy which was carried out on the 
posterior half of the lesion, all 5(100%) patients experienced profused 
bleeding during ablation with the need of continuous need of wiping the area 
with the cotton roll during the procedure, the hemostasis was achieved after 2 
or 3 times of wiping the area with the cotton roll which is denoted by                
score „2‟. 
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Table 24: Comparison of digital photographs to assess wound healing on the 
7
th
, 14
th
 and 21
st
 post- operative day after Diode and Er,Cr:YSGG laser 
procedure: 
 In case 1, It was observed that on the „7th post-operative day‟, in the 
areas treated with both Diode and Er,Cr:YSGG laser showed re- epithelisation 
with no scar formation. On the „14th post-operative day‟, in both the areas 
treated with Diode laser and Er,Cr:YSGG laser showed signs of complete 
healing. On the „21st post- operative day‟, normal buccal mucosa was observed 
with no lesion on the operated site.  
 In case 2, on the „7th post- operative day‟ the patient, was called for a 
review to analyse the outcome of wound healing. In the areas treated with 
Diode laser and Er,Cr:YSGG laser showed signs of re-epithelisation with no 
scaring and slight whitish areas was observed. On the „14th post-operative 
day‟, in both the areas treated with Diode laser and Er,Cr:YSGG laser showed 
signs of complete healing. On the „21st post- operative day‟, normal buccal 
mucosa was observed with no lesion on the operated site.  
 In case 3, on the „7th post-operative day‟ the patient, was called for a 
review to analyse the outcome of wound healing. In the areas treated with 
Diode laser and Er,Cr:YSGG laser showed signs of re-epithelisation with no 
scaring and slight whitish areas was observed. On the „14th post- operative 
day‟, in both the areas treated with Diode laser and Er,Cr:YSGG laser showed 
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signs of complete healing. On the „21st post-operative day‟, normal buccal 
mucosa was observed with no lesion on the operated site. 
 In case 4, on the 7
th
 post-operative day the patient was called for a 
review to analysed the outcome of wound healing. In the areas treated with 
Diode laser and Er,Cr:YSGG laser showed re-epithelisation, no scaring only 
with  whitish areas. On the 14
th 
post- operative
 
day review it was observed that 
in both the areas treated with Diode and Er,Cr:YSGG laser healing was seen 
with mild white areas. On 21
st
 post- operative day normal buccal mucosa was 
observed with no lesion on both the operated areas.  
 In case 5, on the 7
th
 post-operative day, patient had been called for 
review. In the area treated with Diode laser showed signs of re- epithelisation 
with no scarring and the area treated with Er,Cr:YSGG laser showed signs of 
re- epithelisation with pin point bleeding. On the 14
th
 post- operative day, it 
was observed that the wound did not heal completely and whitish areas were 
noticed surrounding the region treated. On further enquiry the patient was not 
able to quit smoking habit. The patient was extremely un co-operative, was not 
willing for any further review and did not return for the 21
st
 post-operative day 
review. 
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Table 1: Comparison of ‘facial expression’ in Behavioral Observation 
Pain Rating Scale between Diode and Er,Cr:YSGG laser 
 
 
Diode Laser 
Er,Cr:YSGG Laser 
 
 
Total 
P Value 
No 
particular 
expression 
or smile; 
disinterested 
Occasional 
grimace or 
frown, 
withdrawn 
Frequent 
constant 
frown, 
clenched 
jaw, 
quivering 
chin 
 
 
 
 
 
 
0.082 
 
 
 
 
 
No particular 
expression or 
smile; 
disinterested 
0 (0%) 3 (60%) 0 (0%) 
3 
(60%) 
Occasional 
grimace or 
frown, 
withdrawn 
0 (0%) 1 (20%) 0 (0%) 
1 
(20%) 
Frequent 
constant frown, 
clenched jaw, 
quivering chin 
0 (0%) 0 (0%) 1 (20%) 
1 
(20%) 
Total 0 (0%) 4 (80%) 1 (20%) 
5 
(100%) 
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Table 2: Comparison of ‘leg movement’ in Behavioral Observation Pain 
Rating Scale between Diode and Er,Cr:YSGG laser 
Diode Laser 
Er,Cr:YSGG Laser 
Total 
P Value 
No position 
or relaxed 
Uneasy, 
restless, 
tense 
Kicking, or 
legs drawn 
up 
0.082 
No position or 
relaxed 
0 (0%) 3 (60%) 0 (0%) 
3 
(60%) 
Uneasy, 
restless, tense 
0 (0%) 1 (20%) 0 (0%) 
1 
(20%) 
Kicking, or 
legs drawn up 
0 (0%) 0 (0%) 1 (20%) 
1 
(20%) 
Total 0 (0%) 4 (80%) 1 (20%) 
5 
(100%) 
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Table 3: Comparison of ‘activity’ of patients during Diode and 
Er,Cr:YSGG laser procedures in Behavioral Observation  
Pain Rating Scale 
Diode Laser 
Er,Cr:YSGG Laser 
Total 
P Value 
Lying 
quietly, 
normal 
position, 
moves easily 
Squirming, 
shifting 
back and 
forth, tense 
Arched, 
rigid, or 
jerking 
0.082 
Lying quietly, 
normal position, 
moves easily 
1 (20%) 3 (60%) 0 (0%) 4 (80%) 
Squirming, 
shifting back 
and forth, tense 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Arched, rigid, 
or jerking 
0 (0%) 0 (0%) 1 (20%) 1 (20%) 
Total 1 (20%) 3 (60%) 1 (20%) 5 (100%) 
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Table 4: Comparison of ‘cry’ of patient in Behavioral Observation Pain 
Rating Scale in between Diode and Er,Cr:YSGG laser 
Diode Laser 
Er,Cr:YSGG Laser 
Total 
P Value 
No crying 
(awake or 
asleep) 
Moans or 
whimpers, 
occasional 
complaint 
Crying 
steadily, 
screams or 
sobs, 
frequent 
complaints 
 
 
 
 
 
 
0.082 
 
 
 
 
 
No crying 
(awake or asleep) 
2 (40%) 2 (40%) 0 (0%) 
4 
(80%) 
Moans or 
whimpers, 
occasional 
complaint 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Cryng steadily, 
screams or sobs, 
frequent 
complaints 
0 (0%) 0 (0%) 1 (20%) 
1 
(20%) 
Total 2 (40%) 2 (40%) 1 (20%) 
5 
(100%) 
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Table 5: Comparison of ‘consolability’ in Behavioral Observation Pain 
Rating Scale in between Diode and Er,Cr:YSGG laser 
Diode Laser 
Er, Cr:YSGG Laser 
Total 
P Value 
Content, 
relaxed 
Reassured by 
occasional 
touching, 
hugging, or 
talking to 
Distractable 
Difficult to 
console or 
comfort 
0.082 
Content, 
relaxed 
2 (40%) 2 (40%) 0 (0%) 
4 
(80%) 
Reassured by 
occasional 
touching, 
hugging, or 
talking to. 
Distractable 
0 (0%) 0 (0%) 0 (0%) 
 
0 (0%) 
Difficult to 
console or 
comfort 
0 (0%) 0 (0%) 1 (20%) 
1 
(20%) 
 
Total 
2 (40%) 2 (40%) 1 (20%) 
5 
(100%) 
 
Table 6: Data analysis of Diode laser and Er,Cr:YSGG laser obtained by 
the use of Behavioral Observation Scale 
 Mean N Std. Deviation 
Std. Error 
Mean 
Sig. 
Diode laser 2.40 5 4.336 1.939 
 
0.061 
 
Er,Cr:YSGG 
laser 
5.00 5 3.082 
 
1.378 
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Table 7: Comparison of pain ‘immediately’ after the procedure between    
Diode laser and Er,Cr:YSGG laser using ‘Faces’ Pain Rating Scale 
Diode 
Laser 
Er,Cr:YSGG Laser 
Total 
P 
Value 
No 
Hurt 
Hurt 
little 
bit 
Hurts 
little 
more 
Hurts 
even 
more 
Hurts 
whole 
lot 
Hurts 
worst 
0.235 
 
No Hurt 0 (0%) 
0 
(0%) 
3 
(60%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
3 
(60%) 
Hurt little 
bit 
0 (0%) 
1 
(20%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
Hurts little 
more 
0 (0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 (0%) 
Hurts 
even more 
0 (0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 (0%) 
Hurts 
whole lot 
0 (0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 (0%) 
Hurts 
worst 
0 (0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
1 
(20%) 
Total 0 (0%) 
1 
(20%) 
3 
(60%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
5 
(100%) 
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Table 8: Comparison of pain on the ‘1st post-operative day’ following the 
day of treatment between Diode laser and Er,Cr:YSGG laser procedure 
using ‘Faces’ Pain Rating Scale 
Diode 
Laser 
Er,Cr:YSGG Laser 
Total 
P 
Value 
No 
Hurt 
Hurt 
little bit 
Hurts 
little 
more 
Hurts 
even 
more 
Hurts 
whole 
lot 
Hurts 
worst 
0.082 
 
No Hurt 0 (0%) 3 (60%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 3 (60%) 
Hurt 
little bit 
0 (0%) 1 (20%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (20%) 
Hurts 
little 
more 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Hurts 
even 
more 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Hurts 
whole 
lot 
0 (0%) 
 
0 (0%) 
 
0 (0%) 
 
0 (0%) 
 
1 
(20%) 
0 (0%) 
 
1 (20%) 
Hurts 
worst 
0 (0%) 
 
0 (0%) 
0 (0%) 
 
0 (0%) 
 
0 (0%) 
 
0 (0%) 
 
0 (0%) 
 
Total 0 (0%) 4 (80%) 0 (0%) 0 (0%) 1(20%) 0 (0%) 5 (100%) 
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Table 9: Comparison of pain on the ‘2nd post-operative day’ following the 
day of treatment between Diode laser and Er,Cr:YSGG laser procedure 
using ‘Faces’ Pain Rating Scale 
Diode 
Laser 
Er,Cr:YSGG Laser 
Total 
P 
Value 
No Hurt 
Hurt 
little 
bit 
Hurts 
little 
more 
Hurts 
even 
more 
Hurts 
whole 
lot 
Hurts 
worst 
0.025 
 
No 
Hurt 
4 
(80%) 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
4 
(80%) 
 
Hurt 
little bit 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Hurts 
little 
more 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Hurts 
even 
more 
0 (0%) 0 (0%) 0 (0%) 
1 
(20%) 
 
0 (0%) 0 (0%) 
1 
(20%) 
Hurts 
whole 
lot 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Hurts 
worst 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Total 
4 
(80%) 
0 (0%) 0 (0%) 
1 
(20%) 
0 (0%) 0 (0%) 
5 
(100%) 
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Table 10: Comparison of pain on the ‘3rd post-operative day’ following 
the day of treatment between Diode laser and Er,Cr:YSGG laser 
procedure using ‘Faces’ Pain Rating Scale 
Diode 
Laser 
Er,Cr:YSGG Laser 
Total 
P 
Value 
No 
Hurt 
Hurt 
little bit 
Hurts 
little 
more 
Hurts 
even 
more 
Hurts 
whole 
lot 
Hurts 
worst 
0.025 
 
No Hurt 
4 
(80%) 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 4 (80%) 
Hurt little 
bit 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Hurts little 
more 
0 (0%) 0 (0%) 
1 
(20%) 
0 (0%) 0 (0%) 0 (0%) 1 (20%) 
Hurts even 
more 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Hurts 
whole lot 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Hurts worst 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Total 
4 
(80%) 
0 (0%) 
1 
(20%) 
0 (0%) 0 (0%) 0 (0%) 
5 
(100%) 
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Table 11: Comparison of pain on the ‘4th post-operative day’ following 
the day of treatment between Diode laser and Er,Cr:YSGG laser 
procedure using ‘Faces’ Pain Rating Scale: 
 
Diode 
Laser 
Er,Cr:YSGG Laser 
 
 
Total 
P 
Value 
No Hurt 
Hurt 
little bit 
Hurts 
little 
more 
Hurts 
even 
more 
Hurts 
whole 
lot 
Hurts 
worst 
0.025 
 
No Hurt 4 (80%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 4 (80%) 
Hurt 
little bit 
0 (0%) 
1 
(20%) 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (20%) 
Hurts 
little 
more 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Hurts 
even 
more 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Hurts 
whole 
lot 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Hurts 
worst 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Total 4 (80%) 
1 
(20%) 
 
0 (0%) 
 
0 (0%) 
 
0 (0%) 
 
0 (0%) 
 
5 
(100%) 
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Table 12: Comparison of pain on the ‘5th, 6th and 7th post operative days’ 
following the day of treatment  between Diode laser and Er,Cr:YSGG 
laser procedure using ‘Faces’ Pain Rating Scale 
Diode 
Laser 
Er,Cr:YSGG Laser 
Total 
P Value 
No Hurt 
Hurt 
little bit 
Hurts 
little 
more 
Hurts 
even 
more 
Hurts 
whole 
lot 
Hurts 
worst 
(a) 
Constant 
 
No Hurt 
5 
(100%) 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
5 
(100%) 
Hurt 
little bit 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Hurts 
little 
more 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Hurts 
even 
more 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Hurts 
whole lot 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Hurts 
worst 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Total 
5 
(100%) 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
5 
(100%) 
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Table 13: Data analysis of Diode laser and Er,Cr:YSGG laser obtained by 
the use of ‘Faces’ Pain Rating Scale 
 Mean N Std. Deviation 
Std. Error 
Mean 
Sig. 
Diode laser 3.40 5 6.542 2.926 
0.001 
Er,Cr:YSGG 
laser 
5.20 5 5.495 5.495 
 
 
 
 
Table 14: ‘Faces’ Pain Rating Scale in Diode and Er,Cr:YSGG laser 
immediately after the procedure and  7
 
post-operative days 
 
Immediately 
After 
treatment 
1
st
  
post 
op 
day 
2
nd
 
post 
op 
day 
3
rd
 
post 
op 
day 
4
th
  
post 
op 
day 
5
th
 
post 
op 
day 
6
th 
post 
op 
day 
7
th
  
post 
op 
day 
P value 
Diode laser 5.80 5.60 4.60 4.40 4.20 3.80 3.80 3.80 0.093 
Er, Cr:YSGG 
laser 
7.90 7.10 4.00 3.80 3.60 3.20 3.20 3.20 0.000 
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Table 15: Comparison of pain ‘immediately’ after the procedure between 
Diode laser and Er,Cr:YSGG laser using Visual Analogue Scale 
Diode 
laser 
Er,Cr:YSGG laser 
Total 
P 
value 
0 1 2 3 4 5 6 7 8 9 10 
0.155 
0 
0 
(0%) 
0 
(0%) 
0 
(0%) 
2 
(40%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
2 
(40%) 
1 
0 
(0%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
1 
(20%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
2 
(40%) 
2 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
3 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
4 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
5 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
6 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
7 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
8 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
9 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
10 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
1 
(20%) 
Total 
0 
(0%) 
0 
(0%) 
0 
(0%) 
3 
(60%) 
1 
(20%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
5 
(100%) 
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Table 16: Comparison of pain on the
 ‘
1
st
 post-operative day’ following the 
day of treatment between Diode laser and Er,Cr:YSGG laser post 
operatively using Visual Analogue Scale 
Diode 
laser 
Er,Cr:YSGG laser 
Total 
P 
value 
0 1 2 3 4 5 6 7 8 9 10 
0.040 
0 0 
(0%) 
0 
(0%) 
3 
(60%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
3 
(60%) 
1 0 
(0%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
2 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
3 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
4 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
5 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
6 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
7 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
8 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
9 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
10 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Total 0 
(0%) 
0 
(0%) 
3 
(60%) 
1 
(20%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
0 
(0%) 
0 
(0%) 
5 
(100%) 
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Table 17: Comparison of pain on the
 ‘
2
nd
 post-operative day’ following the 
day of procedure between Diode laser and Er,Cr:YSGG laser post 
operatively using Visual Analogue Scale 
Diode 
laser 
Er, Cr:YSGG laser 
Total 
P 
value 
0 1 2 3 4 5 6 7 8 9 10 
 
0.025 
0 0 
(0%) 
4 
(80%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
4 
(80%) 
1 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
2 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
3 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
4 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
5 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(20%) 
6 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
7 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
8 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
9 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
10 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Total 0 
(0%) 
4 
(80%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
5 
(100%) 
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Table 18: Comparison of pain on the
 ‘
3
rd
 post-operative day’ following the 
day of treatment between Diode laser and Er,Cr:YSGG laser post 
operatively using Visual Analogue Scale 
Diode 
laser 
Er, Cr:YSGG laser 
Total 
P 
value 
0 1 2 3 4 5 6 7 8 9 10 
 
0.025 
0 4 
(80%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
4 
(80%) 
1 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
2 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
3 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
4 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
5 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
6 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
7 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
8 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
9 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
10 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Total 4 
(80%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
5 
(100%) 
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Table 19: Comparison of pain on the
 ‘
4
th
 post-operative day’ following the 
day of treatment between Diode laser and Er,Cr:YSGG laser post 
operatively using Visual Analogue Scale 
Diode 
laser 
Er, Cr:YSGG laser 
Total 
P 
value 
0 1 2 3 4 5 6 7 8 9 10 
0.025 
0 4 
(80%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
4 
(80%) 
1 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
2 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
3 0 
(0%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
4 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
5 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
6 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
7 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
8 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
9 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
10 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Total 4 
(80%) 
0 
(0%) 
0 
(0%) 
1 
(20%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
5 
(100%) 
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Table 20: Comparison of pain on the
 ‘
5
th
, 6
th
 and 7
th
 post-operative days’ 
following the day of treatment between Diode laser and Er,Cr:YSGG 
laser using Visual Analogue Scale 
Diode 
laser 
Er,Cr:YSGG laser 
Total 
P 
value 
0 1 2 3 4 5 6 7 8 9 10 
0.(a) 
Constant 
0 5 
(100%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
5 
(100%) 
1 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
2 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
3 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
4 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
5 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
6 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
7 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
8 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
9 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
10 0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Total 5 
(100%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
5 
(100%) 
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Table 21: Data analysis of Diode laser and Er,Cr:YSGG laser obtained by 
the use of Visual Analogue Scale 
 Mean N Std. Deviation 
Std. Error 
Mean 
Sig. 
Diode 
laser 
6.60 5 13.107 5.862 
0.000 
Er,Cr:YS
GG laser 
11.4 5 10.991 4.915 
 
Table 22: Visual Analogue Scale in Diode and Er,Cr:YSGG laser 
immediately after the procedure and 7
 
post-operative days 
 
Immediately 
After treatment 
1
st
  post 
op day 
2
nd
 post 
op day 
3
rd
 post 
op day 
4
th
  post 
op day 
5
th
  post 
op day 
6
th
post 
op day 
7
th
 post 
op day 
P value 
Diode laser 6.50 5.50 4.50 4.30 4.10 3.70 3.70 3.70 0.025 
Er,Cr:YSGG
laser 
8.00 7.00 6.00 3.40 3.20 2.80 2.80 2.80 0.000 
 
 
Table 23: Comparison of Bleeding during the procedure between Diode 
and Er,Cr:YSGG laser 
 Case 1 Case 2 Case 3 Case 4 Case 5 
Diode laser 1 1 1 1 1 
Er, Cr:YSGG 
laser 
2 2 2 2 2 
 Tables and Graphs 
  
 
Table 24: Comparison of digital photographs after Diode laser and 
Er,Cr:YSGG laser procedure to assess wound healing on the 7
th
, 14
th
 and 
21
st
 post operative days 
Case 
No. 
Days Diode Laser Er,Cr:YSGG Laser 
Case 1 
7
th
 day Re- epithelisation /no 
scarring 
Re-  epithelisation/ no 
scarring 
14
th
 day Complete healing Complete healing 
21
st
 day Normal buccal mucosa Normal buccal mucosa 
Case 2 
7
th
 day Re- epithelisation / no 
scarring with slight 
whitish areas 
Re-  epithelisation / no 
scarring  with slight whitish 
areas 
14
th
 day Complete healing Complete healing 
21
st
 day Normal buccal mucosa Normal buccal mucosa 
Case 3 
7
th
 day Re- epithelisation / no 
scarring with slight 
whitish areas 
Re- epithelisation / no 
scarring with slight whitish 
areas 
14
th
 day Complete healing Complete healing 
21
st
 day Normal buccal mucosa Normal buccal mucosa 
Case 4 
7
th
 day Re- epithelisation / no 
scarring with slight 
whitish areas 
Re- epithelisation / no 
scarring with slight whitish 
areas 
14
th
 day Healing with mild whitish 
areas 
Healing with mild whitish 
areas 
21
st
 day Normal buccal mucosa Normal buccal mucosa 
Case 5 
7
th
 day Signs of re- epithelisation 
seen with no scarring 
Signs of re- epithelisation 
with pin – point bleeding 
14
th
 day No successful healing, 
whitish area surrounding 
the region 
No successful healing, 
whitish area surrounding the 
region 
21
st
 day Not willing for review- 
Did not report back 
Not willing for review- Did 
not report back 
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Graph 1: Comparison of ‘facial expression’ in Behavioral Observation 
Pain Rating Scale between Diode and Er,Cr:YSGG laser 
 
 
 
Graph 2: Comparison of ‘leg movement’ in Behavioral Observation Pain 
Rating Scale between Diode and Er,Cr:YSGG laser 
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Graph 3: Comparison of ‘activity’ of patients during Diode and 
Er,Cr:YSGG laser procedures in Behavioral Observation  
Pain Rating Scale 
 
 
Graph 4: Comparison of ‘cry’ of patient in Behavioral Observation Pain 
Rating Scale in between Diode and Er,Cr:YSGG laser 
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Graph 5: Comparison of ‘consolability’ in Behavioral Observation Pain 
Rating Scale in between Diode and Er,Cr:YSGG laser 
 
 
 
Graph 6: Data analysis of Diode laser and Er,Cr:YSGG laser obtained by 
the use of Behavioral Observation Scale 
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Graph 7: Comparison of pain immediately after the procedure on the                   
‘1st day’ between Diode laser and Er,Cr:YSGG laser using ‘Faces’ Pain 
Rating Scale 
 
 
Graph 8: Comparison of pain on the ‘2st day’ after procedure between 
Diode laser and Er,Cr:YSGG laser procedure using ‘Faces’  
Pain Rating Scale 
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Graph 9: Comparison of pain on the ‘3rd day’ after procedure between 
Diode laser and Er,Cr:YSGG laser procedure using ‘Faces’ Pain  
Rating Scale 
 
 
Graph 10: Comparison of pain on the ‘4th day’ after procedure between 
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Diode laser and Er,Cr:YSGG laser procedure using ‘Faces’ Pain  
Rating Scale 
 
 
Graph 12: Comparison of pain on the ‘6th and 7th day’ after procedure 
between Diode laser and Er,Cr:YSGG laser procedure using ‘Faces’ Pain 
Rating Scale 
 
 Tables and Graphs 
  
Graph 13: Data analysis of Diode laser and Er,Cr:YSGG laser obtained 
by the use of ‘Faces’ Pain Rating Scale 
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Graph 19: Comparison of pain on the
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Graph 21: Data analysis of Diode laser and Er,Cr:YSGG laser obtained 
by the use of Visual Analogue Scale 
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Graph 23: Comparison of Bleeding during the procedure between Diode 
and Er,Cr:YSGG laser 
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WHO (2005) declared that the term “leukoplakia should be used to 
recognize white patch of questionable risk having excluded other known 
diseases or disorders that carry no increased risk for cancer”.44 
 Many causative agents have been implicated in the etiology of 
leukoplakia. They include tobacco, alcohol, chronic friction due to sharp tooth, 
electro galvanic reaction, UV radiation, syphilis and so on.
45 
Tobacco use is 
considered to be the primary cause for occurrence of leukoplakia.
46 
 There seems no well accepted treatment method for removal of oral 
leukoplakia. Leukoplakia is limited to the epithelium, so selected removal of 
this part of the mucosa seems to be the best choice of treatment. 
 There are different treatment modalities adopted for leukoplakia once 
it has occurred. First and foremost any tobacco related habits have to be 
stopped forthwith to be followed by administration of retinoids and other 
drugs or other surgical procedures such as surgical excision, cryosurgery, laser 
surgery and photo dynamic therapy.
3 
 Laser surgery has been the latest treatment modality for leukoplakia. 
Different soft tissue lasers, semiconductor Diode laser and hard tissue lasers 
can be used for the treatment of oral leukoplakia. Today there are different 
types of lasers available and used in dentistry such as Nd:YAG, Holmium: 
Yttrium, Aluminium, Garnet, Er,Cr:YSGG laser, Nd:YAP, GaAs, Diode and 
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Argon laser. Thus different types of lasers are used for different soft tissue 
surgeries.
6 
 In comparison with conventional scalpel therapy, laser has many 
benefits such as ease of soft tissue ablation, hemostasis, instant sterilization, 
reduced bacteremia, reduced edema due to reduced mechanical trauma, and 
little wound contraction resulting in minimal scar, less intra- operative and 
post- operative pain, increased patient acceptance or few sutures, no need for 
topical anesthesia.
9,16 
 Diode lasers are semiconductor lasers and are generally considered to 
be soft tissue lasers. Diode lasers have a solid active medium, manufactures 
from semiconductor crystals, using some combination of Aluminium, Gallium 
and Arsenide. The available wavelengths are 810nm, 940nm and 980nm. 
Laser with wavelength of 810nm is highly absorbed by melanin and 
hemoglobin, whereas those of 940nm and 980nm are strongly absorbed by 
hemoglobin and water.
8 
 
Er,Cr:YSGG laser belongs to the Erbium family. They are hard tissue 
lasers with a wavelength of 2780nm and contain Yttrium, Scandium, Gallium, 
Garnet doped with Erbium and Chromium. This laser is well absorbed by 
water enabling it to be used on soft tissues without causing thermal 
damage.
12,13 
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 The present study was conducted in the department of Oral Medicine 
& Radiology, Ragas Dental College & Hospital, Chennai. This was a 
comparative study conducted between March 2012 to June 2012. The study 
population included five subjects reporting to Ragas Dental College and 
Hospital, Out-patient department seeking dental advice and who were from a 
wide variety of socio- economic background. The age group selected was 
above 18 years. 
 Clinical examination was done on all the patients coming to out- 
patient, five subjects were selected who were provisionally diagnosed as 
having oral leukoplakia involving the length and width of the buccal mucosa 
measuring minimum of 10mm and the lesion was measured and entered in a 
case sheet proforma. History of habits, such as smoking, alcohol consumption 
and tobacco chewing was recorded in the case sheet proforma with the 
duration and frequency of use. The patients were advised to cease the habit 
and were explained about the laser therapy modality. Informed consent to 
participate in the study were obtained from each of the five patients included 
in the study in a written format both in vernacular and English language. The 
treatment was undertaken at Smile Dental Clinic, T.Nagar, Chennai.  
 On all the five patients laser biopsy was done using Diode laser 
(940nm, power of 1.00 Watt, 615 Joules using contact mode) including the 
lesion and the normal mucosa. The specimen was stored in 10% formalin and 
was transported for histopathological analysis to the oral pathologist. After the 
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specimen was histopathologically confirmed as oral leukoplakia the laser 
treatment was started. Each patient was then prepared by dividing the lesions 
into two halves with the help of a hematoxylin marker with the maxillary and 
mandibular premolars being the reference points. Anterior to the marked line, 
the lesion on the buccal mucosa was treated with Diode laser. The Diode laser 
(Ezlase 940, Biolase, USA) was used in the wavelength of 940nm, power of 
1.00 watt, 615 Joules using contact mode. The lesion area posterior to the 
marked line on the buccal mucosa was treated with Er,Cr:YSGG laser. The 
Er,Cr:YSGG laser (Waterlase MD, Biolase, USA) was used in the wavelength 
of 2780nm, S mode, 1.5W, Air-30% and Water 10%, MZ , 25 Hz.  
 During the procedure the patients were assessed for pain with the use 
of Behavioral Observational Pain Rating Scale and the scores were entered in 
the case sheet. Bleeding was assessed intra-operatively during the Diode and 
Er,Cr:YSGG laser procedures and the results were then entered into the case 
sheet proforma. If there was minimal bleeding then it was scored „1‟ and if 
there was profuse bleeding then it was scored as „2‟. 
 The patients were assessed for post-operative pain using „Faces‟ Pain 
Rating Scale starting from day one immediately after the procedure and day 
after the procedure for all 7 post- operative days. They were asked to denote 
pain which they were experiencing by identifying the emotion icon on the 
scale. The emotion icons expressed were then correlated to a scale which was 
divided into six scores ranging from 0-5. The pain scores on the day of 
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treatment and for the 7 post- operative days following the day of treatment 
were then entered into the case sheet proforma for each case for both Diode 
and Er,Cr:YSGG laser procedures. 
 The Visual Analogue Scale was used to assess pain which was 
experienced by the patient immediately after the procedure and for 7 post- 
operative days following treatment scoring pain with a scale ranging from 0 to 
10. Asking the patient to score the experience of pain with „0‟ denoting no 
pain,„5‟denoting distressing pain,„10‟denoting unbearable pain and if 
experienced pain between these ranges denoted by respected numbers from          
1-4, 6-9. The scores were entered into the case sheet proforma. 
 Photographs were taken using DSLR camera (Nikon 550D) during the 
treatment and on 7
th
, 14
th
 and 21
st
 post- operative days to assess wound healing 
by visual method. 
 All the data‟s were then entered in Microsoft excel sheets. Statistical 
analysis was done using SPSS software SYSTAT Version 15.0. The statistical 
analysis was done using Chi- Square test, Independent and Paired ‟t‟ test and 
Friedman test. 
 The test of significance with p- value less than 0.05 at 95% confidence 
interval is taken to correlate the variables to determine the significance. 
 
  
Discussion 
  
 
61 
 
DATA ANALYSIS: 
PAIN ANALYSIS: 
 In the present study pain was assessed for each patient using 
Behavioral Pain Rating Scale separately during the Diode laser procedure and 
Er,Cr:YSGG laser procedure. On comparing the results obtained from all five 
patients, Behavioral Pain Rating Scale yielded insignificant results with a                 
p-value of 0.061. 
 So far no study has been reported in the literature using the Behavioral 
Pain Rating Scale to compare between Diode laser and Er,Cr:YSGG laser. In 
this study for the first time we have attempted to analyze pain using 
Behavioral Pain Rating Scale in Diode laser and Er,Cr:YSGG laser in the 
treatment of oral leukoplakia. 
 A diagrammatic representation of the pain experienced by the patient  
using „Faces‟ Pain Rating Scale was assessed immediately after the laser 
surgery using Diode and Er,Cr:YSGG laser and seven consecutive days post- 
operatively starting from the next day after treatment. The emotion icons 
expressed were then correlated to a scale which was divided into six scores 
ranging from 0-5. Data analysed from the „Faces‟ Pain Rating Scale 
comparing Diode laser and Er,Cr:YSGG laser on all five patients yielded 
significant result with a p-value of 0.001 which implied that pain experienced 
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by patients with Diode laser procedure was less in comparison to the use of 
Er,Cr:YSGG laser. 
 In this present study the analysis of pain reduction post-operatively 
yielded insignificant results in „Faces‟ Pain Rating Scale with a p-value of 
0.093 with Diode laser and with Er,Cr:YSGG laser highly significant results 
were obtained which showed that pain gradually reduced from the first day 
after treatment and patient experienced no pain on the 5
th
, 6
th
 and 7
th
                  
post- operative days in all five patients with Diode and Er,Cr:YSGG laser. 
 No study has been reported using the „Faces‟ Pain Rating Scale 
comparing Diode laser and Er,Cr:YSGG laser. This present study is an attempt 
to analyse pain using „Faces‟ Pain Rating Scale comparing Diode laser and 
Er,Cr:YSGG laser in the treatment of oral leukoplakia. 
 In this present study Visual Analogue Scale was also used in all five 
patients to assess pain experienced by patient after the Diode and Er,Cr:YSGG 
laser procedure. It was observed that the mean value with Diode laser was 
3.40 and with Er,Cr:YSGG laser was 5.20. On comparing Diode laser and 
Er,Cr:YSGG laser to assess pain the Visual Analogue Scale yielded highly 
significant results with a p- value of 0.000. This implied that Diode laser 
procedure caused minimal pain when compared to Er,Cr:YSGG laser in 
treatment of oral leukoplakia. 
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  It was observed in the present study that pain reduced gradually after 
the treatment with no pain experienced by the patient on the 5
th,
 6
th
 and 7
th
 
post- operative days in both Diode and Er,Cr:YSGG laser. The analysis 
yielded significant results with Diode laser with p- value of 0.025 and yielded 
with Er,Cr:YSGG laser. 
 In the present study the post- operative analysis as expressed by each 
individual patient using „Faces‟ Pain Rating Scale and Visual Analogue Scale 
is unique with the sense that each patient had separately experienced both the 
laser procedures using Diode laser and Er,Cr:YSGG laser and that their 
experiences of pain under each procedure became all the more significant in 
comparing both the procedures than if it were done by two different groups of 
unrelated patients under each laser procedure. 
             It is to be noted that so far no study has been reported in the literature 
using the Behavioral Pain Rating Scale and „Faces‟ Pain Rating Scale to 
compare Diode laser and Er,Cr:YSGG laser. We have attempted to analyze 
pain using Behavioral Pain Rating Scale and „Faces‟ Pain Rating Scale along 
with Visual Analogue Scale in applying Diode laser and Er,Cr:YSGG laser in 
the treatment of oral leukoplakia. 
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BLEEDING ANALYSIS: 
 In this present study bleeding was assessed visually during both the 
Diode laser and Er,Cr:YSGG laser procedure. It was found that during Diode 
treatment in all five patients minimal bleeding was observed during ablation 
and needed only occasional wiping of the area, whereas during Er,Cr:YSGG 
laser ablation in all five patients profused bleeding was observed which 
needed continuous wiping of the area with cotton roll, hemostasis was 
achieved after 2-3 times of wiping the area with the cotton roll. 
 This is in accordance to the study conducted by George Romanos et 
al (1999)
27
 in which Diode laser (980nm) was used in the removal of soft 
tissue tumors and was observed that minimal bleeding was seen. Goharkhay 
et al (1999)
28
 used Diode laser with 810nm wavelength on soft tissue lesions 
resulted in excellent coagulation ability. Deppe, H and H.H Horch (2007)
3
 
reviewed the use of Diode laser in removal of premalignant lesions of oral 
mucosa and concluded minimal bleeding during treatment. Also the present 
study is in accordance to Prajwalit Kende et al (2011)
33
 whose case report of 
excisional biopsies performed on oral premalignant lesion using Diode laser 
indicated reduced operative blood loss. 
 The Er,Cr:YSGG laser procedure in this present study showed profuse 
bleeding which is in accordance to the study reported by Lee SC (1998)
36
 who 
concluded that hemostatic ability is limited with use of Er,Cr:YSGG laser 
  
Discussion 
  
 
65 
 
because only the water on the surface of the blood in the surgical site is 
vaporized. There is neither deep penetration nor sustained heat to provide 
rapid vessel shrinkage. 
 In the present study hemostasis was well achieved with the use of 
Diode laser than Er,Cr:YSGG laser which is in accordance with the study 
conducted by Stabholz A et al (2003)
39
 which describes that hemostasis is 
better achieved by use of Diode laser than Er,Cr:YSGG laser because Diode 
laser are well absorbed by melanin and hemoglobin. There wavelengths   
(810-980nm) will pass through water and penetrate much deeper into the soft 
tissue unlike Erbium laser where they are not well absorbed by these 
chromophores concluding that Erbium family lasers are not ideal wavelength 
for soft tissue surgeries in which ideal hemostasis is desired. 
WOUND HEALING ANALYSIS: 
 In this present study it was observed that both Diode and Er,Cr:YSGG 
laser in all five patients showed signs of re- epithelisation with no scarring on 
the 7
th
 post- operative day, whereas with three patients out of 5 showed slight 
whitish areas on the 7
th
 post- operative day. Complete healing was observed in 
all five patients on the 14
th
 post – operative with the use of both Diode and 
Er,Cr:YSGG laser. And four patients out of five showed normal buccal 
mucosa on the 21
st
 day. Except for one patient who showed no successful 
healing with whitish area surrounding the region on 14
th
 post- operative day 
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with the use of both Diode and Er,Cr:YSGG laser and the patient was not 
willing for anymore review and did not return back on the 21
st
 day. The 
patient gave the reason of unable to quit smoking and alcohol consumption 
and was obviously continuing with the habits all through the post- operative 
period rendering the healing process to fail. 
 In this study it was observed that out of five patients except for one 
patient all other showed excellent wound healing at the 21
st
 post- operative 
day which is in accordance to George Romanos et al (1999)
27
, Mona 
Soliman et al (2005)
29
, Depp,H and HH Horch (2007)
3
, Nilesh Ravel et al 
(2011)
34
 . 
          George Romanos et al (1999)
27
 in their study, examined wound healing 
of soft tissue after application of Diode laser and concluded that good wound 
healing was observed. Mona Soliman et al (2005)
29
 also showed similar 
results with complete wound healing after second week in treatment of oral 
lichen planus with Diode laser. Depp,H and HH Horch (2007)
3
 in their study 
also concluded that premalignant lesions treated with Diode laser showed 
excellent wound healing. In accordance to the present study, a study 
conducted by Nilesh Ravel et al (2011)
34
 showed complete wound healing 
with the use of Diode laser. 
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 In the similar way Er,Cr:YSGG laser in this present study showed 
excellent wound healing which is in accordance to the study conducted by 
Rizolu et al (1996)
35
 and Boj et al (2007).
20 
 
          Rizolu et al (1996)
35
 in their study concluded that all 12 mucocutaneous 
soft tissues treated using Er,Cr:YSGG laser showed good signs of re- 
epithelisation. And Boj et al (2007)
20 
study on squamous cell papilloma 
treated with Er,Cr:YSGG laser also showed excellent wound healing similar to 
this present study. 
 In this present study Diode laser and Er,Cr:YSGG laser showed good 
wound healing after 14
th
 post- operative day which is not in accordance to the 
study conducted by Jin et al (2010)
41
 which was a comparative study to assess 
healing of buccal mucosa in 24 guines pigs and it was concluded that Diode 
laser has better effect on wound healing when compared to Er,Cr:YSGG laser. 
This contradiction may be due to the fact that in the study conducted by              
Jin et al (2010)
42 
on buccal mucosa of guinea pigs were used in assessing the 
healing, whereas in our study healing was assessed in buccal mucosa of 
humans. 
 So the best test species for humans are humans. It is not possible to 
extrapolate animal data to humans, due to inter- species variation in anatomy, 
physiology and bio-chemistry.
47 
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 This present study was conducted to compare the effectiveness of 
Diode laser (940nm) and Er,Cr:YSGG laser (2780nm) in the treatment of oral 
leukoplakia. The study was undertaken in the department of Oral Medicine & 
Radiology, Ragas Dental College & Hospital, Uthandi and Smile Dental 
Clinic, T.Nagar, Chennai. Five subjects were selected for the laser treatment 
who were provisionally diagnosed and histopathologically confirmed as 
having oral leukoplakia involving the buccal mucosa. 
 In each patient the lesion was marked into two halves and the anterior 
part was treated with Diode laser and the posterior half with Er,Cr:YSGG 
laser. Two different lasers were used to treat two separate halves of the same 
lesion in order to compare the pain experienced by the patient with the use of 
both lasers and also to compare bleeding during procedure and wound healing 
on 7
th
, 14
th
 and 21
st
 post- operative days simultaneously. 
 This is a pioneer study, as previously no studies have been reported in 
the literature comparing the effectiveness of Diode laser (940 nm) and 
Er,Cr:YSGG laser (2780 nm) in the treatment of oral leukoplakia. 
 In this present study pain has been assessed using three different Pain 
Rating Scales such as Behavioral Pain Rating Scale, ‘Faces’ Pain Rating Scale 
and Visual Analogue Scale. This is the first time that all three Pain Rating 
Scales have been incorporated in assessing pain. 
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The following results were obtained from this present study: 
1. Comparing and assessing for each patient using Behavioral Pain 
Rating Scale during the Diode laser and Er,Cr:YSGG laser procedure 
yielded insignificant result with p- value of 0.061. 
2. The ‘Faces’ Pain Rating Scale yielded significant result with a p-value 
of 0.001 which implied that pain experienced by patients with Diode 
laser procedure was less in comparison to use of Er,Cr:YSGG laser. 
And it was noted that pain gradually reduced from the first post-
operative day after treatment and patient experienced no pain on the 
5
th
,6
th
,7
th
 post- operative days in all five patients with Er,Cr:YSGG 
laser and Diode laser. 
3. The Visual Analogue Scale yielded highly significant result with a             
p- value of 0.000 which implied that Diode procedure caused minimal 
pain when compared to Er,Cr:YSGG laser in the treatment of oral 
leukoplakia and pain reduced gradually after treatment with no pain 
experienced on the 5
th
, 6
th
, 7
th
 post- operative day in both Diode laser 
and Er,Cr:YSGG laser. 
4. In the present study hemostasis was well achieved with the use of 
Diode laser than Er,Cr:YSGG laser because Diode laser (940nm) is 
well absorbed by hemoglobin. No comparative study has been 
previously conducted to analyze hemostasis between the Diode laser 
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and Er,Cr:YSGG laser in the treatment of oral leukoplakia but has 
comparative studies on other soft tissue lesions. 
5. And in the present study both Diode laser and Er,Cr:YSGG laser 
showed soft tissue wound healing after 14
th
 post–operative day. This is 
the first time a comparative study has been conducted to assess wound 
healing using Diode laser and Er,Cr:YSGG laser in the treatment of 
oral leukoplakia. 
 This pioneer study in which the effectiveness of Diode laser with a 
wavelength of 940 nm has been compared with the effectiveness of 
Er,Cr:YSGG laser with a wavelength of 2780 nm which is a hard tissue laser. 
In this present study it was noted that both Diode laser and Er,Cr:YSGG laser 
showed excellent wound healing post- operatively concluding that both the 
lasers can be used in the treatment of oral leukoplakia. In relation to 
hemostasis, Diode laser was found to be superior to Er,Cr:YSGG laser as 
Diode laser is well absorbed by hemoglobin, whereas Er,Cr:YSGG laser is 
absorbed by water and hydroxyappetite crystal. In relation to pain, Diode  
laser caused minimal pain when compared to Er,Cr:YSGG laser which caused 
more pain during the procedure except for one patient who experienced severe 
pain with the use of both the lasers which concluded that pain can be 
subjective. Diode laser is less painful when compared to Er,Cr:YSGG laser 
because the wavelength of 940nm is less when compared to Er,Cr:YSGG laser 
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wavelength which is about 2780 nm which could cause more thermal damage 
causing more pain compared to Diode laser. 
 Moreover Diode laser was portable and easy to handle and less 
expensive when compared to Er,Cr:YSGG laser. 
 The study concluded that Diode laser with the wavelength of 940nm 
can be used in the treatment of oral leukoplakia with no to minimal pain , 
excellent hemostasis and wound healing with no post- operative complications 
and Er,Cr:YSGG laser being a hard tissue laser with a wavelength of 2780nm 
caused minimal discomfort to patient and profuse bleeding during procedure 
and good healing outcome in treatment of oral leukoplakia concluding that 
Er,Cr:YSGG laser can also be considered in the treatment of oral leukoplakia. 
 While comparing both the lasers, in this present study it has been 
concluded that Diode laser (940nm) is superior to that of Er,Cr:YSGG laser in 
treating oral leukoplakia. 
 Considering the small sample size used in this present study, the study 
with large proportion of samples may be necessary to confirm the results of 
our study conclusively. 
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smoking 
duration 
smoking frequency 
alcohol 
duration 
alcohol frequency 
Chewing 
duration 
chewing 
frequency 
Size of Lesion 
Type of 
Leukoplakia 
20 9 15 15 5 3 3 2 
7 6 7 15 0 0 2 1 
7 6 7 15 0 0 2 1 
10 9 10 4 0 0 2 1 
25 15 25 15 15 3 2 1 
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RAGAS DENTAL COLLEGE AND HOSPITAL 
Department of Oral Medicine and Radiology 
CASE HISTORY PROFORMA 
Comparing the Effectiveness of Diode Laser and Er,Cr:YSGG Laser in the 
treatment of Oral Leukoplakia. 
OP No:                                                                         Date:  
Serial No: 
Name:                                                                            
Age:   years:               Gender: Male / Female 
Occupation:                  Monthly income: Rs. 
Address: 
Phone number: 
Chief Complaint: 
 Duration 
History of Presenting Illness: 
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Past Medical History: 
Personal History: Habits with duration, frequency and intensity 
 Smoking: 
 Cigarette  : 
 Beedi        : 
 Pipe          : 
 Hookah    : 
 Reverse smoking : 
Smoke less tobacco consumption: 
Alcohol consumption: 
Intraoral Examination:  
B) Soft Tissue Examination: Lesion:                                                                       
Site  -                                                                                 
Size -                                                                                 
Type -                                                                               
Extent-                                                                             
Scrapable/ Non- Scrapable                                              
Provisional Diagnosis: 
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Histopathological Report:        
                                       
 
I. Dates on which the treatment was commenced and the follow- up: 
Diode Laser and Er,Cr:YSGG Laser Therapy: 
Day of 
Treatment 
7
th
 post 
operative day 
14
th 
post 
operative day 
21
st
 post 
operative day 
    
 
II. Pain Scale of patient assessed for the study: 
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III. Bleeding scored during both Diode laser and Er,Cr:YSGG laser 
procedure:  
 
BLEEDING 
Minimal Profuse 
1 2 
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LETTER INFORMED CONSENT  
 I,   …………………………………………………………., the 
undersigned hereby give my consent for using the Diode Laser and Erbium, 
Chromium: YSGG laser for the treatment of white lesion on the cheek inside 
my mouth, for the study of „Comparing the effectiveness of Diode laser and 
Er,Cr:YSGG laser in the treatment of Oral leukoplakia‟ by Dr. Sonali Sarkar 
under the guidance of Dr. S. Kailasam, Professor and Head, Department of 
Oral Medicine and Radiology, Ragas Dental College and Hospital, Chennai-
600119. I have been informed and explained the status of my disorder, 
evaluation procedure, risk involved in the treatment and the likelihood of the 
outcome. I also understand and accept this as part of the study protocol there 
by voluntarily, unconditionally and freely give my consent to participate in the 
study without any fear or pressure in a mentally sound and conscious state.  
Patient‟s signature 
Witness / representative:                                                     
Date: 
Place: 
 
 
 
  
Annexure III  
 
 
Xg;g[jy; gotk; 
-------------------------------------------------- vd;fpd;w ehd;/ brd;id uhfh!; gy; 
kUj;Jtf; fy;Y}hp kw;Wk; kUj;Jtkidapd; tha; kUj;Jtk; 
kw;Wk; CLfjph; Jiwapy; nguhrphpah; kU. ifyh!k; mth;fspd; 
nkw;ghh;itapy;/ KJepiy (M.D.S) gl;lg;gog;g[ gapYk;                  
kU. nrhdhyp rh;fhh;  mth;fs; nkw;bfhs;Sk; “tha; cl;g[wj;jpR 
btz;glyj;Jf;fhd rpfpr;irapy; Er,Cr:YSGG nyrh; kw;Wk; 
ilnahL nyrh; rpfpr;irKiwapd; nkk;ghl;oid xg;gpl;L 
mika[k; Ma;t[” vd;fpd;w Muha;r;rpf;fhd ghpnrhjidfSf;F 
vd;id cl;gLj;Jtjw;F vdJ kdKte;j ghpg{uz rk;kjj;jpid 
mspf;fpnwd;. 
nkYk; vdf;F vd;Dila nehapd; jd;ikiagw;wpa[k;/ 
mjdhy; Vw;glf;Toa tpist[fisg;gw;wpa[k; vLj;Jf; 
Twg;gl;Ls;sJ vdt[k;/ ,e;j ghpnrhjidf;F ehd; ve;jtpj 
mr;rKkpd;wp jd;dpr;irahft[k;/ bjspthd KG kdJld; 
vd;Dila ghpg{uz rk;kjj;jpid mspf;fpnwd; vd ,jd; \yk; 
bjhpag;gLj;Jfpnwd;. 
 
 
rhl;rpahsh;fs;:       ,g;gof;F 
